Global Smart Insulin or Glucose Responsive Insulin Market , 2021-2027
- GEN4646476
- 85 Pages
- June 2021
- Healthcare
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global smart insulin or glucose responsive insulin market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, company share of market leaders, growth rate and market segments.
The smart insulin or glucose responsive insulin market is segmented on the basis of delivery devices, disease, type, and region. The smart insulin or glucose responsive insulin market is segmented as below:
By Delivery Devices:
- smart insulin pens
- smart insulin pumps
By Disease:
- type 1 diabetes
- type 2 diabetes
By Type:
- intermediate-acting insulin
- long-acting insulin
- pre-mixed insulin
- rapid-acting insulin
- short-acting insulin
By Region:
- region
- Asia-Pacific
- Europe
- North America
- Middle East and Africa (MEA)
- South America
The market research report covers the analysis of key stake holders of the smart insulin or glucose responsive insulin market. Some of the leading players profiled in the report include Diamesco Co., Ltd., Eli Lily and Company, Insulet Corporation, Medtronic Plc, Novo Nordisk A/S, Roche Holding AG, Sanofi S.A., Tandem Diabetes Care, Inc., Zealand Pharma A/S, among others.
*list is not exhaustive, request free sample to get a complete list of companies
Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global smart insulin or glucose responsive insulin market.
- To classify and forecast the global smart insulin or glucose responsive insulin market based on delivery devices, disease, type, and region.
- To identify drivers and challenges for the global smart insulin or glucose responsive insulin market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global smart insulin or glucose responsive insulin market.
- To conduct pricing analysis for the global smart insulin or glucose responsive insulin market.
- To identify and analyze the profile of leading players operating in the global smart insulin or glucose responsive insulin market.
Why Choose This Report
- Gain a reliable outlook of the global smart insulin or glucose responsive insulin market forecasts from 2021 to 2027 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive Summary
Part 4. Market Overview
4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic
Part 5. Global Market for Smart Insulin or Glucose Responsive Insulin by Delivery Devices
5.1 Smart Insulin Pens
5.1.1 Market Size and Forecast
5.2 Smart Insulin Pumps
5.2.1 Market Size and Forecast
Part 6. Global Market for Smart Insulin or Glucose Responsive Insulin by Disease
6.1 Type 1 Diabetes
6.1.1 Market Size and Forecast
6.2 Type 2 Diabetes
6.2.1 Market Size and Forecast
Part 7. Global Market for Smart Insulin or Glucose Responsive Insulin by Type
7.1 Intermediate-Acting Insulin
7.1.1 Market Size and Forecast
7.2 Long-Acting Insulin
7.2.1 Market Size and Forecast
7.3 Pre-Mixed Insulin
7.3.1 Market Size and Forecast
7.4 Rapid-Acting Insulin
7.4.1 Market Size and Forecast
7.5 Short-Acting Insulin
7.5.1 Market Size and Forecast
Part 8. Global Market for Smart Insulin or Glucose Responsive Insulin by Region
8.1 Asia-Pacific
8.1.1 Market Size and Forecast
8.2 Europe
8.2.1 Market Size and Forecast
8.3 North America
8.3.1 Market Size and Forecast
8.4 Middle East And Africa (Mea)
8.4.1 Market Size and Forecast
8.5 South America
8.5.1 Market Size and Forecast
Part 9. Key Competitor Profiles
9.1 Diamesco Co., Ltd.
9.2 Eli Lily and Company
9.3 Insulet Corporation
9.4 Medtronic Plc
9.5 Novo Nordisk A/S
9.6 Roche Holding AG
9.7 Sanofi S.A.
9.8 Tandem Diabetes Care, Inc.
9.9 Zealand Pharma A/S
*LIST IS NOT EXHAUSTIVE
Part 10. Patent Analysis
10.1 Patent Statistics
10.2 Regional Analysis
10.3 Trends Analysis
DISCLAIMER
ABOUT GEN CONSULTING COMPANY
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
